Newbridge Financial Services Group’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6K Buy
+4,600
New +$15.9K ﹤0.01% 687
2025
Q3
Sell
-19
Closed -$259 1342
2025
Q2
$259 Hold
19
﹤0.01% 1259
2025
Q1
$103 Hold
19
﹤0.01% 1010
2024
Q4
$94 Sell
19
-3,081
-99% -$16.2K ﹤0.01% 1107
2024
Q3
$16.2K Buy
+3,100
New +$17.9K 0.01% 380
2024
Q2
Sell
-1,000
Closed -$10.3K 1171
2024
Q1
$10.3K Hold
1,000
﹤0.01% 764
2023
Q4
$8.29K Buy
+1,000
New +$7.19K ﹤0.01% 778
2021
Q4
Sell
-4,000
Closed -$25K 1486
2021
Q3
$25K Buy
+4,000
New +$34.1K 0.02% 597

Other funds holding LFMD

Newbridge Financial Services Group's LFMD Position: Q1 2026 in Review

Newbridge Financial Services Group opened a new position in LifeMD (LFMD) in Q1 2026: 4,600 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #687 among its holdings. This is a return to the name: Newbridge Financial Services Group previously reported a position in LFMD as recently as Q2 2025.

Newbridge Financial Services Group first reported a position in LFMD in Q3 2021 and has held it in 8 quarters since. The position peaked at $25K in Q3 2021. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Newbridge Financial Services Group held 4,600 shares of LifeMD worth $16.6K as of Q1 2026.
  • LifeMD was a new Newbridge Financial Services Group position in Q1 2026.
  • LifeMD made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #687 holding.
  • Newbridge Financial Services Group first reported a position in LifeMD in Q3 2021 and has held it in 8 quarters since.
  • Newbridge Financial Services Group's LifeMD position peaked at $25K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.